Publicaciones en las que colabora con Esther Navarro Manzano (9)

2024

  1. Deconstructing neutrophil to lymphocyte ratio (NLR) in early breast cancer: lack of prognostic utility and biological correlates across tumor subtypes

    Breast Cancer Research and Treatment

2023

  1. A new prognostic model including immune biomarkers, genomic proliferation tumor markers (AURKA and MYBL2) and clinical-pathological features optimizes prognosis in neoadjuvant breast cancer patients

    Frontiers in Oncology, Vol. 13

  2. Clinical Meaning of Stromal Tumor Infiltrating Lymphocytes (sTIL) in Early Luminal B Breast Cancer

    Cancers, Vol. 15, Núm. 10

2022

  1. Prognostic and Predictive Effects of Tumor and Plasma miR-200c-3p in Locally Advanced and Metastatic Breast Cancer

    Cancers, Vol. 14, Núm. 10

2020

  1. Mitochondrial DNA drives abscopal responses to radiation that are inhibited by autophagy

    Nature Immunology, Vol. 21, Núm. 10, pp. 1160-1171

2019

  1. Clinical and biological impact of miR-18a expression in breast cancer after neoadjuvant chemotherapy

    Cellular Oncology, Vol. 42, Núm. 5, pp. 627-644

  2. Neutrophil-lymphocyte ratio in metastatic breast cancer is not an independent predictor of survival, but depends on other variables

    Scientific Reports, Vol. 9, Núm. 1

2018

  1. Angiogenic role of miR-20a in breast cancer

    PLoS ONE, Vol. 13, Núm. 4

  2. Circulating small-sized endothelial microparticles as predictors of clinical outcome after chemotherapy for breast cancer: an exploratory analysis

    Breast Cancer Research and Treatment, Vol. 169, Núm. 1, pp. 83-92